Cancer-specific epigenetic alterations as investigated from a pharmaceutical perspective [electronic resource] / Thomas A. Paul.
Material type: FilmSeries: Henry Stewart talksBiomedical & life sciences collection: Publisher: London : Henry Stewart Talks, 2021Description: 1 online resource (1 streaming video file (34 min.) : color, sound)Subject(s): Antineoplastic agents -- Development | Cancer -- Genetic aspects | Epigenesis | Antineoplastic Agents -- pharmacology | Chromatin Assembly and Disassembly -- genetics | Epigenesis, Genetic | Histone Deacetylase Inhibitors | Neoplasms -- drug therapy | Neoplasms -- geneticsOnline resources: Click here to access onlineAnimated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Chromatin dysregulation in cancer -- Features of epigenetic information in cells -- Mutated chromatin regulatory factors as tumor drivers -- Therapeutic rationale for the use of epigenetic drugs in oncology -- First generation epigenetic drugs: DNMT and HDAC inhibitors -- Novel therapeutic discoveries in oncology -- Biomarkers for patient selection.
Access restricted to subscribers.
Mode of access: World Wide Web.